Back
Adverum Biotechnologies Vs. EyePoint Pharmaceuticals Industry Stock Comparison
Sell
45
ADVM
Adverum Biotechnologies
Last Price:
7.55
Seasonality Move:
2.22%
Sell
50
EYPT
EyePoint Pharmaceuticals
Last Price:
8.65
Seasonality Move:
-4.78%
Sell
45
Adverum Biotechnologies (ADVM)
is a Sell
Is Adverum Biotechnologies a Buy, Sell or Hold?
- The current Adverum Biotechnologies [ADVM] share price is $7.53. The Score for ADVM is 45, which is 10% below its historic median score of 50, and infers higher risk than normal.
- ADVM is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
50
EyePoint Pharmaceuticals (EYPT)
is a Sell
Is EyePoint Pharmaceuticals a Buy, Sell or Hold?
- The current EyePoint Pharmaceuticals [EYPT] share price is $8.63. The Score for EYPT is 50, which is 0% below its historic median score of 50, and infers higher risk than normal.
- EYPT is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
ADVM Stock Price Chart
What is Adverum Biotechnologies's stock price today?
-
The Adverum Biotechnologies share price today is $7.53
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ADVM is experiencing slight buying pressure.
EYPT Stock Price Chart
What is EyePoint Pharmaceuticals's stock price today?
-
The EyePoint Pharmaceuticals share price today is $8.63
The current trend is relatively stagnant and EYPT is experiencing buying pressure, which is a positive indicator for future bullish movement.
ADVM Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0 | Buy |
| Relative Strength Index (14 RSI): | 57.98 | Buy |
| Chaikin Money Flow: | 127164 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (6.74 - 7.28) | Buy |
| Bollinger Bands (100): | (6.75 - 7.97) | Buy |
EYPT Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.1 | Sell |
| Relative Strength Index (14 RSI): | 53.06 | Buy |
| Chaikin Money Flow: | 175844 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (8.04 - 8.82) | Buy |
| Bollinger Bands (100): | (8.03 - 10.31) | Sell |
ADVM Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 6.92 | Buy |
| 20-day SMA: | 7.06 | Buy |
| 50-day SMA: | 7.03 | Buy |
| 200-day SMA: | 10.34 | Sell |
| 8-day EMA: | 7.08 | Buy |
| 20-day EMA: | 7.03 | Buy |
| 50-day EMA: | 7.2 | Buy |
| 200-day EMA: | 9.3 | Sell |
EYPT Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 8.18 | Buy |
| 20-day SMA: | 8.46 | Buy |
| 50-day SMA: | 8.6 | Buy |
| 200-day SMA: | 15.81 | Sell |
| 8-day EMA: | 8.33 | Buy |
| 20-day EMA: | 8.4 | Buy |
| 50-day EMA: | 8.79 | Sell |
| 200-day EMA: | 11.92 | Sell |
Adverum Biotechnologies Earnings Growth & ADVM Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.02 per share, a decrease next quarter of $0.00 per share, an increase this year of $7.62 per share, and an increase next year of $0.42 per share.
EyePoint Pharmaceuticals Earnings Growth & EYPT Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.21 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.42 per share, and a decrease next year of $0.94 per share.
Adverum Biotechnologies Technical Analysis
| Sep 23 | Sep 24 | Sep 25 | Sep 26 | Sep 27 | Sep 30 | Oct 1 | Oct 2 | Oct 3 | Oct 4 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | Oct | |||||||||
| 23 | 24 | 25 | 26 | 27 | 30 | 01 | 02 | 03 | 04 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
EyePoint Pharmaceuticals Technical Analysis
| Sep 23 | Sep 24 | Sep 25 | Sep 26 | Sep 27 | Sep 30 | Oct 1 | Oct 2 | Oct 3 | Oct 4 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | Oct | |||||||||
| 23 | 24 | 25 | 26 | 27 | 30 | 01 | 02 | 03 | 04 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||